Red Blood Cells as a Reflection of Endothelial Function in Old Age

NCT ID: NCT02265003

Last Updated: 2021-02-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to find out, how far red blood cells reflect age-depended changes in endothelial function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It will be investigated with determination of endothelial function (measured as flow-mediated vasodilation) and of circulated nitric oxid-pool in red blood cells and in blood plasma, how far red blood cells reflect age-depended changes in endothelial function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Red Blood Cells Endothelial Function Nitric Oxide Pool in Red Blood Cells and Blood Plasma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy young age

Healthy subjects in age of 18-35 years, without cardiac dysrhythmia, hypertension, diabetes mellitus, acute inflammations and terminal kidney disease

No interventions assigned to this group

Healthy middle age

Healthy subjects in age of 35-45 years, without cardiac dysrhythmia, hypertension, diabetes mellitus, acute inflammations and terminal kidney disease

No interventions assigned to this group

Healthy old

Healthy subjects in age of \>70 years, without cardiac dysrhythmia, hypertension, diabetes mellitus, acute inflammations and terminal kidney disease

No interventions assigned to this group

Patients

Patients with atherosclerosis

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy subjects
* informed consent


* angiographical signs of apparent atherosclerosis (cardiac artery disease or peripheral vascular disease or degenerative valvular heart disease)
* informed consent

Exclusion Criteria

* hypertension (blood pressure ≥140/90 mmHg),
* hypercholesterolemia (LDL ≥250 mg/dl, HDL ≤45 mg/dl),
* diabetes mellitus (fasting plasma glucose ≥128 mg/dl)
* acute inflammation (CRP \>0.5 mg/dl)
* malignant diseases
* heart failure (NYHA III-IV)
* arrhythmia of high degree
* acute or terminated kidney disease
* cardiovascular diseases ( cardiac artery disease, peripheral vascular disease and cerebrovascular diseases)
* anemia
* pregnancy

Group 4 :


* Hypertension (blood pressure ≥140/90 mmHg),
* Hypercholesterolemia (LDL ≥250 mg/dl, HDL ≤45 mg/dl),
* Diabetes mellitus (fasting plasma glucose ≥128 mg/dl)
* acute inflammation (CRP \>0.5 mg/dl)
* malignant diseases
* heart failure (NYHA III-IV)
* arrhythmia of high degree
* acute or terminated kidney disease
* cardiovascular diseases ( cardiac artery disease, peripheral vascular disease and cerebrovascular diseases)
* anemia
* pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Heinrich-Heine University, Duesseldorf

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Klinik für Kardiologie, Pneumologie und Angiologie

Principle Investigator Prof. Dr. Malte Kelm

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Malte Kelm, Prof. MD

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiology, Pneumology and Angiology, University Hospital Duesseldorf

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Duesseldorf

Düsseldorf, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14-016

Identifier Type: OTHER

Identifier Source: secondary_id

Anaemie

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.